In the days of the Armada, a fleet of warships, the scuttlebutt was the rumor or gossip that would spread throughout the ship. Today, Armada Law Corp presents The Scuttlebutt, a daily summery of news articles that people within the cannabis, hemp and plant medicine industries are chatting about along with links to the full articles.
In today’s news:
#cannabispolitics – “The cannabis policy arena in 2022 saw three more states legalize adult-use marijuana, the president take the historic step of using executive action to order a review of the drug’s federal status, and Congress pass its first standalone piece of cannabis reform.
Rhode Island, Maryland and Missouri each legalized cannabis for adult use this year — the latter two by voter-led ballot referenda, the former via the state legislature — bringing the total number of states where cannabis is legal for recreational use to 21.
But the year also saw voters reject three initiatives in the traditionally conservative states of Arkansas, North Dakota and South Dakota — the biggest defeat for legalizers in a decade of breakneck liberalization of cannabis laws.
While most federal reforms stalled out, including a thwarted last-minute effort to push a cannabis banking reform called the SAFE Banking Act through the Senate in the lame-duck session, lawmakers did succeed in enacting one major piece of bipartisan cannabis policy paving the way for more research into the drug’s medicinal uses — research that has historically been cumbersome thanks to marijuana’s Schedule I status.”
#cannabisindustry – “A new bill prefiled in Washington State this week represents the latest effort to expand U.S. cannabis markets across state lines. With similar laws already on the books in Oregon and California, passage would set the stage for marijuana products to travel legally up and down the West Coast and beyond.
Even if the interstate cannabis commerce bill becomes law in the coming session, however, actual cross-border marijuana deals couldn’t commence without approval from the federal government.”
#psychedelicresearch – “The findings of the study, led by UCR doctoral ethnomusicology student Owain J. Graham, were published in the journal Anthropology of Consciousness. Graham said the topic of his research needs to be further explored and the role of music as a therapeutic tool better understood so that music can be more effectively integrated in healing treatment options for patients in the United States, and potentially globally, suffering from addictions and other illnesses.
About 67% of participants who completed a nine-to-12-month program at Takiwasi Center, did not return to substance abuse, according to previous research cited by Graham and his colleagues. About 86% of patients showed statistically significant improvements on the Addictions Severity Index, an assessment tool used to evaluate substance abuse treatment.”
#cbdproducts – “Alphabet Inc.’s Google in January will start running ads for some products made with CBD for the first time, in a program designed to test the loosening of its rules on promoting the cannabis-derived substance formally called cannabidiol.
The news represents a small breakthrough for CBD product owners, which have long been blocked by some technology companies from advertising online.
“Google’s decision to open the door for some CBD products to advertise is a step in the right direction,” said Lisa Buffo, founder and chief executive of the Cannabis Marketing Association. “The opportunity for businesses to connect with their customers, where they are, is long overdue.””
#cannabisindustry – “Asia is beginning to warm up to the use of cannabis. Thailand legalised marijuana cultivation at home in 2022, while South Korea, Japan and Malaysia are paving the way for pharmaceutical applications. With the weed market estimated to be a $100 billion industry by 2026, according to research firm Prohibition Partners, regional businesses are preparing for demand from Asian consumers.”
Armada Law Corp offers licensing and compliance services across all 50 states…
#cannabisindustry – “The D.C. Council last week gave its unanimous and final approval to a bill that makes sweeping changes to the District’s medical cannabis program, capping a long and obstacle-ridden journey for the legislation, which was introduced nearly two years ago. It now heads to Mayor Muriel Bowser’s desk for a signature, and then to Congress for review.
In its final form, the 78-page Medical Cannabis Amendment Act loosens a slew of restrictions on dispensaries and cultivators, lifts a cap on the number of licenses regulators can issue, and gives unregulated weed businesses a path to legality while cracking down on those that don’t fall in line. It also takes new steps to prioritize entrepreneurs harmed by the so-called War on Drugs, and renames the D.C. agency charged with regulating weed from the Alcoholic Beverage Regulation Administration (ABRA) to the Alcoholic Beverage and Cannabis Administration (ABCA).”